ArticleHeart and vessels2019

Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabetic-metabolic syndrome patients with coronary artery disease.

Akihiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.